Status:
COMPLETED
Local Control After Robot-assisted Supraglottic Laryngectomy
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Supraglottic Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Transoral robotic surgery is an option to treat supraglottic squamous cell carcinomas. Oncological outcomes 2 years after transoral robotic surgery for supraglottic laryngectomy were studied.
Eligibility Criteria
Inclusion
- Men or women over 18 years of age
- Patients with supra-glottic squamous cell carcinoma from T1 to T3, all stages N
- Patients with a robot assisted supra-glottic laryngectomy with at least 2 years follow-up
Exclusion
- Patients for whom follow-up of at least 2 years has not been achieved;
- Major patients protected by the law (under guardianship or guardianship);
- Patients who expressed opposition to their participation in the study.
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2017
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT03357107
Start Date
October 1 2016
End Date
February 28 2017
Last Update
November 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Croix-Rousse Hospital, Hospices Civils de Lyon
Lyon, France, 69004